This aspect could represent an advantage for the application of CD-NSs, since CAV-1 is down-regulated in the vast majority of ovarian carcinomas 60, and its expression greatly change in different type of cancers, depending on tumor staging and the tumor microenvironment 61. Here, CAV1 is linked to neoplasm.